<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">Zika </span>
   <span class="font30">vaccine </span>
   <span class="font29">virus </span>
   <span class="font23">ZIKV </span>
   <span class="font17">infection </span>
   <span class="font16">research </span>
   <span class="font15">clinical </span>
   <span class="font15">development </span>
   <span class="font15">vaccines </span>
   <span class="font14">responses </span>
   <span class="font14">Early-stage </span>
   <span class="font14">{border-style </span>
   <span class="font13">Med </span>
   <span class="font13">outbreaks </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">immune </span>
   <span class="font13">models </span>
   <span class="font13">mice </span>
   <span class="font13">phase </span>
   <span class="font13">studies </span>
   <span class="font13">antibody </span>
   <span class="font13">disease </span>
   <span class="font13">immunity </span>
   <span class="font12">Health </span>
   <span class="font12">proteins </span>
   <span class="font12">inactivated </span>
   <span class="font12">Aedes </span>
   <span class="font12">Research </span>
   <span class="font12">Vaccine </span>
   <span class="font12">dengue </span>
   <span class="font12">developed </span>
   <span class="font12">neutralizing </span>
   <span class="font12">protein </span>
   <span class="font12">Mayo </span>
   <span class="font12">World </span>
   <span class="font12">cases </span>
   <span class="font12">different </span>
   <span class="font12">human </span>
   <span class="font12">pregnant </span>
   <span class="font12">women </span>
   <span class="font11">(eg, </span>
   <span class="font11">Infect </span>
   <span class="font11">animal </span>
   <span class="font11">fetal </span>
   <span class="font11">large </span>
   <span class="font11">likely </span>
   <span class="font11">safety </span>
   <span class="font11">syndrome </span>
   <span class="font11">trials </span>
   <span class="font11">vaccine. </span>
   <span class="font11">viral </span>
   <span class="font11">(ie, </span>
   <span class="font11">African </span>
   <span class="font11">Clinic </span>
   <span class="font11">RNA </span>
   <span class="font11">T-cell </span>
   <span class="font11">antibodies </span>
   <span class="font11">candidates </span>
   <span class="font11">global </span>
   <span class="font11">health </span>
   <span class="font11">need </span>
   <span class="font11">protect </span>
   <span class="font11">protection </span>
   <span class="font11">provide </span>
   <span class="font11">px; </span>
   <span class="font11">recombinant </span>
   <span class="font11">require </span>
   <span class="font11">response </span>
   <span class="font11">results </span>
   <span class="font11">severe </span>
   <span class="font11">spread </span>
   <span class="font11">study </span>
   <span class="font11">{font-family </span>
   <span class="font11">DNA </span>
   <span class="font11">Dis </span>
   <span class="font11">February </span>
   <span class="font11">cell </span>
   <span class="font11">congenital </span>
   <span class="font11">countries </span>
   <span class="font11">current </span>
   <span class="font11">font-size </span>
   <span class="font11">funding </span>
   <span class="font11">important </span>
   <span class="font11">include </span>
   <span class="font11">live </span>
   <span class="font11">major </span>
   <span class="font11">multiple </span>
   <span class="font11">number </span>
   <span class="font11">public </span>
   <span class="font11">rhesus </span>
   <span class="font11">significant </span>
   <span class="font11">strains </span>
   <span class="font11">symptoms </span>
   <span class="font11">titers </span>
   <span class="font11">transmission </span>
   <span class="font11">type </span>
   <span class="font11">use </span>
   <span class="font11">virus. </span>
   <span class="font11">Asian </span>
   <span class="font11">Engl </span>
   <span class="font11">Guillain-Barr√© </span>
   <span class="font11">Preclinical/animal </span>
   <span class="font11">attenuated </span>
   <span class="font11">causes </span>
   <span class="font11">challenge </span>
   <span class="font11">dose </span>
   <span class="font11">double; </span>
   <span class="font11">effective </span>
   <span class="font11">effects </span>
   <span class="font11">envelope </span>
   <span class="font11">following </span>
   <span class="font11">future </span>
   <span class="font11">given </span>
   <span class="font11">infected </span>
   <span class="font11">issues </span>
   <span class="font11">lack </span>
   <span class="font11">measles </span>
   <span class="font11">model </span>
   <span class="font11">neurologic </span>
   <span class="font11">new </span>
   <span class="font11">nonstructural </span>
   <span class="font11">recent </span>
   <span class="font11">reported </span>
   <span class="font11">single </span>
   <span class="font11">vaccines, </span>
   <span class="font11">French </span>
   <span class="font11">Institute </span>
   <span class="font11">Live </span>
   <span class="font11">NS, </span>
   <span class="font11">Public </span>
   <span class="font11">Purified </span>
   <span class="font11">adults </span>
   <span class="font11">areas </span>
   <span class="font11">booster </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">candidate </span>
   <span class="font11">challenge. </span>
   <span class="font11">fever, </span>
   <span class="font11">humoral </span>
   <span class="font11">immunogenicity </span>
   <span class="font11">increased </span>
   <span class="font11">individuals </span>
   <span class="font11">infection, </span>
   <span class="font11">infection. </span>
   <span class="font11">issue </span>
   <span class="font11">limited </span>
   <span class="font11">mRNA </span>
   <span class="font11">macaques </span>
   <span class="font11">older </span>
   <span class="font11">outbreak </span>
   <span class="font11">population </span>
   <span class="font11">product </span>
   <span class="font11">profile </span>
   <span class="font11">protective </span>
   <span class="font11">relatively </span>
   <span class="font11">resulted </span>
   <span class="font11">revealed </span>
   <span class="font11">risk </span>
   <span class="font11">safe </span>
   <span class="font11">solid; </span>
   <span class="font11">strain </span>
   <span class="font11">world </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">Africa </span>
   <span class="font10">COVID- </span>
   <span class="font10">Centers </span>
   <span class="font10">Conflict </span>
   <span class="font10">Control </span>
   <span class="font10">DENV </span>
   <span class="font10">Disease </span>
   <span class="font10">Elsevier </span>
   <span class="font10">GBS </span>
   <span class="font10">Hyg </span>
   <span class="font10">IFN </span>
   <span class="font10">Japanese </span>
   <span class="font10">NSB, </span>
   <span class="font10">Trop </span>
   <span class="font10">VLP </span>
   <span class="font10">Virol </span>
   <span class="font10">Yap </span>
   <span class="font10">ZIKV. </span>
   <span class="font10">ability </span>
   <span class="font10">adults, </span>
   <span class="font10">analysis </span>
   <span class="font10">animals </span>
   <span class="font10">associated </span>
   <span class="font10">background </span>
   <span class="font10">bold </span>
   <span class="font10">centre </span>
   <span class="font10">childbearing </span>
   <span class="font10">children, </span>
   <span class="font10">clear </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">detected </span>
   <span class="font10">develop </span>
   <span class="font10">em; </span>
   <span class="font10">epidemic </span>
   <span class="font10">established </span>
   <span class="font10">ethical </span>
   <span class="font10">expressing </span>
   <span class="font10">flaviviruses </span>
   <span class="font10">immunity. </span>
   <span class="font10">immunization </span>
   <span class="font10">including </span>
   <span class="font10">innate </span>
   <span class="font10">known </span>
   <span class="font10">lineages </span>
   <span class="font10">microcephaly </span>
   <span class="font10">modified </span>
   <span class="font10">mosquito </span>
   <span class="font10">mouse </span>
   <span class="font10">nonhuman </span>
   <span class="font10">novel </span>
   <span class="font10">occur. </span>
   <span class="font10">pathology </span>
   <span class="font10">prM </span>
   <span class="font10">prevent </span>
   <span class="font10">prior </span>
   <span class="font10">protected </span>
   <span class="font10">pt;} </span>
   <span class="font10">range </span>
   <span class="font10">regarding </span>
   <span class="font10">related </span>
   <span class="font10">report </span>
   <span class="font10">required </span>
   <span class="font10">resource </span>
   <span class="font10">shown </span>
   <span class="font10">significantly </span>
   <span class="font10">spectrum </span>
   <span class="font10">studies, </span>
   <span class="font10">systematic </span>
   <span class="font10">target </span>
   <span class="font10">tested </span>
   <span class="font10">time </span>
   <span class="font10">using </span>
   <span class="font10">vaccine-induced </span>
   <span class="font10">vaccines. </span>
   <span class="font10">variety </span>
  </p>
 </body>
</html>
